Search

Author/Creator Broermann, Andre

1. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis. (17th January 2018)

Authors:
Baader, Manuel; Bretschneider, Tom; Broermann, Andre; Rippmann, Joerg F; Stierstorfer, Birgit; Kuttruff, Christian A; Mark, Michael
Journal:
British journal of pharmacology
Issue:
Volume 175:Number 4(2018)
Page Start:
693
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH. Issue 5 (24th February 2022)

Authors:
Møllerhøj, Mathias B.; Veidal, Sanne S.; Thrane, Kirstine Tølbøl; Oró, Denise; Overgaard, Agnete; Salinas, Casper Gravesen; Madsen, Martin Rønn; Pfisterer, Larissa; Vyberg, Mogens; Simon, Eric; Broermann, Andre; Vrang, Niels; Jelsing, Jacob; Feigh, Michael; Hansen, Henrik H.
Journal:
Clinical and translational science
Issue:
Volume 15:Issue 5(2022)
Page Start:
1167
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Modulation of vascular contraction via soluble guanylate cyclase signaling in a novel ex vivo method using rat precision‐cut liver slices. Issue 3 (20th May 2021)

Authors:
Oldenburger, Anouk; Birk, Gerald; Schlepütz, Marco; Broermann, Andre; Stierstorfer, Birgit; Pullen, Steven S.; Rippmann, Jörg F.
Journal:
Pharmacology research & perspectives
Issue:
Volume 9:Issue 3(2021)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗